Venous Thromboembolism After Spinal Cord Injury: Incidence, Time Course, and Associated Risk Factors in 16,240 Adults and Children

Size: px
Start display at page:

Download "Venous Thromboembolism After Spinal Cord Injury: Incidence, Time Course, and Associated Risk Factors in 16,240 Adults and Children"

Transcription

1 2240 ORIGINAL ARTICLE Venous Thromboembolism After Spinal Cord Injury: Incidence, Time Course, and Associated Risk Factors in 16,240 Adults and Children Tracey Jones, MD, Viviane Ugalde, MD, Peter Franks, MD, Hong Zhou, PhD, Richard H. White, MD ABSTRACT. Jones T, Ugalde V, Franks P, Zhou H, White RH. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil 2005;86: Objective: To analyze the incidence of venous thromboembolism (VTE) after spinal cord injury (SCI). Design: Retrospective cohort analysis of all SCI cases (16,240) in California from 1991 through Setting: All public hospitals in California. Participants: Subjects (cases) coded as having complete or incomplete SCI. Interventions: Not applicable. Main Outcome Measure: Diagnosis of VTE or death within 91 days of the day of hospital admission. Results: For all cases, the 91-day cumulative incidence of VTE was 5.4%. In a multivariate model, significant predictors of VTE included male sex (odds ratio [OR] 1.4; 95% confidence interval [CI], ), African-American race (OR 1.6; 95% CI, ), complete paraplegia versus tetraplegia (OR 1.8; 95% CI, ), and presence of 3 or more comorbid conditions versus none (OR 1.6; 95% CI, ). Age less than 14 years was predictive of not developing VTE (OR 0.2; 95% CI, ). The incidence of VTE did not change significantly over the 11-year time period (P.07), and VTE was not a significant predictor of death in the first 91 days after hospitalization. Conclusions: The incidence of VTE in SCI patients in California did not change between 1991 and We identified specific risk factors for VTE. Further studies are needed to determine if prompt initiation of medical prophylaxis in high risk subjects reduces the incidence of symptomatic VTE. Key Words: Pulmonary embolism; Rehabilitation; Spinal cord injuries; Thromboembolism; Venous thrombosis by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation VENOUS THROMBOEMBOLISM (VTE), a term that encompasses both deep vein thrombosis (DVT) and pulmonary embolism (PE), has been reported to develop in 8% to From the Department of Physical Medicine and Rehabilitation (Jones, Ugalde), Center for Health Services Research in Primary Care, Department of Family & Community Medicine (Franks), and Division of General Medicine (Zhou, White), University of California, Davis, CA. Supported by the Hibbard E. Williams Endowment for Medical Research, UC Davis. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated. Reprint requests to Richard H. White, MD, Div of General Internal Medicine, Ste 2400, PSSB, 4150 V Street, Sacramento, CA 95817, rhwhite@ucdavis.edu /05/ $30.00/0 doi: /j.apmr % of patients with spinal cord injury (SCI). 1-3 Clinical studies using venography have found that SCI patients have an extremely high incidence of asymptomatic VTE, as high as 48% to 100% among patients not given any medical thromboprophylaxis. 2,4,5 Variations in the reported incidence of symptomatic VTE after SCI are probably due to differences in the severity and location of the injury, presence of associated trauma or comorbid conditions, and differences in the use, dose, or duration of medical thromboprophylaxis. 6-9 Prevention of VTE is important because PE is a leading cause of death of SCI patients. 10,11 The incidence of VTE in SCI patients decreased significantly from the late 1970s until the early 1990s, 12 a period characterized by increased use of subcutaneous heparin thromboprophylaxis. It is not known whether the incidence of VTE has continued to decrease in the last 15 years, a period characterized by widespread use of low molecular weight heparin (LMWH) prophylaxis. Moreover, although some reports have suggested that in SCI patients, age over 50 years, lowerextremity fracture, and delayed use of prophylaxis, are predictors of VTE, 4 it is not clear what independent risk factors are most strongly associated with clinically symptomatic VTE in these patients. One difficulty in determining the important risk factors associated with development of VTE is the small size and low power of most SCI studies. 4,9 Even the recent National Spinal Cord Injury Statistical Center registry report 1 provided information on only 700 selected SCI patients concerning the incidence of VTE. We assembled a large cohort of SCI cases using the State of California Patient Discharge Data Set and determined the incidence of VTE over an 11-year period, from January 1991 to December Analysis of a data set of that size can identify certain demographic and clinical risk factors associated with the development of symptomatic VTE. Based on reports in the literature, we hypothesized that: (1) the incidence of VTE would decrease slowly over the 11-year period, 1 (2) prepubertal children would have a significantly lower incidence of VTE than adults and postpubertal teenagers, 13 (3) patients with complete paraplegia or tetraplegia would have a higher incidence of VTE than patients with partial cord injuries, 3 and (4) patients with VTE would not survive as long as those who did not develop VTE. 10,11 METHODS Design and Database The California Patient Discharge Data Set has been described elsewhere. 14 All nonfederal hospitals supply specific information about each inpatient, including basic demographic data, the principal diagnosis, up to 24 secondary diagnoses, a principal procedure, and as many as 20 secondary procedures, using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes. Since July 1990, encrypted record linkage numbers have made it possible to

2 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones 2241 link serial hospitalizations. 15 This study was approved by the California Health and Welfare Agency Committee for the Protection of Human Subjects and the Human Subjects Committee, University of California, Davis. Study Cohort We analyzed all cases admitted from January 1, 1991, to December 31, 2001, that were coded as acute SCI with fracture of the vertebral column (ICD-9-CM, code 806.xx), or SCI without fracture (code 952.xx). Cases were subcategorized as complete paraplegia, complete tetraplegia, incomplete paraplegia, incomplete tetraplegia, unspecified paraplegia, unspecified tetraplegia, or unspecified injury (appendix 1). Fewer than 1% of all cases were hospitalized for longer than 91 days and they were excluded from this analysis as outliers. All cases with a prior diagnosis of VTE were also excluded. Index hospitalization was defined as any period of continuous hospitalization in 1 or more hospitals after the injury (eg, acute care facility to rehabilitation hospital). Placement of an inferior vena cava (IVC) filter (ICD-9-CM code 38.7) within 91 days was noted. Definition of Outcomes Principal outcomes were death and the incidence of VTE (PE or DVT) during the index hospital stay, within 91 days, and within 1 year of the date of hospitalization. Deaths were determined from a state death registry linked to the discharge database. PE was defined by the ICD-9-CM code 415.1x, and DVT in the lower extremity was defined by codes 451.1x, 451.2, , 451.9, 453.1, 453.2, 453.8, and Codes for superficial venous thrombosis and upper-extremity venous thrombosis were not included. Cases coded as having both DVT and PE were categorized as having PE. Each VTE case was categorized as very likely or likely based on the following criteria. Very likely included all cases with a secondary diagnosis of VTE coupled with a code for a diagnostic test for thromboembolism, specifically compression venous ultrasound, ventilation perfusion lung scan, helical scan of chest, etc (codes or 88.44, 88.66, 92.15, 88.77, 87.41, 89.59, 38.7, 99.19), or cases readmitted with a principal diagnosis of VTE coupled with a length of stay (LOS) of 3 or more days (unless death occurred). Likely included cases with a secondary code for VTE and LOS of 3 or more days (unless death occurred). Validation studies have shown that the positive predictive value among cases meeting criteria for very likely is more than 90%, whereas cases meeting criteria for likely have a positive predictive value for objectively confirmed VTE between 72% to 95%. 17,18,20 However, 2 factors associated with lower positive predictive value were excluded from the definition of VTE namely, prior VTE and an LOS for VTE of less than 2 days. Comorbidity Comorbidity was defined using a modified Elixhauser Comorbidity Index. 21 Major elements in this index of 30 serious comorbidities include congestive heart failure, chronic obstructive pulmonary disease, diabetes, etc, but VTE is not included. For our analysis, we removed paralysis from the index. Presence of other factors associated with development of VTE was determined based on specific ICD-9-CM codes: pelvic or lowerextremity fractures (codes 808.x, 820.x, 821.x, 823.x), tracheostomy (code 31.x), and any rehospitalization within 91 days of the injury. We also analyzed the effect of index hospital size on outcomes. Hospitals (N 470) were categorized as large university or university-affiliated (n 9), hospitals with more than 350 beds (n 27), hospitals with between 251 and 350 beds (n 67), hospitals with 125 to 250 beds (n 106), and hospitals with fewer than 125 beds (n 261). We determined the number of cases that were transferred to a second hospital from the index hospital. The source of payment was also analyzed after cases were classified according to the principal payer: insurance or health maintenance organization, Medi-Cal, Medicare, indigent, and other. Statistical Analysis Data were analyzed using Stata. a Continuous variables were compared using the Student t test, and categoric data were analyzed using the chi-square test or Fisher exact test. We used linear regression to test for trends in the incidence of VTE and of SCI in California. Logistic rather than proportional hazard models were generated because the exact day of VTE diagnosis could not be determined for a significant proportion of the cases. Analyses were adjusted for the clustering of observations within hospitals by using a generalized estimating equations approach, with robust sandwich estimators of variance and an independent within-group correlation structure assumed. Age was modeled as a discrete variable, using age 30 to 49 years as the referent. Hospital LOS was not included because diagnosis of VTE likely leads to an increase in the length of hospitalization. To adjust for any secular trends in the incidence of VTE over time, we included calendar year in the models. To determine which specific chronic comorbid conditions were associated with the development of VTE, variables not significantly associated (P.05) were removed by backward elimination. RESULTS There were 16,240 cases coded as having SCI during the 11-year study period. The demographic and clinical characteristics of the entire cohort and of the cases that did or did not develop VTE within 1 year of hospitalization are summarized in table 1. The subjects mean age was 44 years, and the average length of index hospitalization was 18 days. Figure 1 shows the age and sex distribution of the SCI cohort. As shown in figure 2, the standardized incidence ( popest/archives) of SCI patients admitted to California hospitals decreased significantly over the 11-year period (cases/ 100,000 population/year, r 0.9, P.002), whereas there was a trend toward a higher percentage of SCI cases developing VTE over the same period, which was not statistically significant (P.07). The number of ultrasound tests that were coded as being performed increased from approximately 115 (7.3% of cases) from 1991 to 1993 to 183 cases in 1994 (11.8% of cases), but thereafter the number decreased to 115 (7.5% of cases) in The cumulative incidence of VTE was 774 (4.8%) during the index hospital stay, 883 (5.4%) within 91 days and 977 (6.0%) within 1 year after index hospitalization. The relation between age and the incidence of VTE during these 3 time periods is shown in figure 3. Among cases diagnosed within 91 days, 45% were classified as very likely and 55% were classified as likely; 76% had DVT and 24% had PE. Cases 60 to 69 years old had the highest cumulative incidence of VTE (8%). In bivariate analyses, the incidence of VTE within 91 days of hospitalization was significantly higher among men (5.9%) than women (4.1%) (P.001). Only 2 of 181 children (1.1%) 13 years or younger were diagnosed with VTE within 91 days, compared with 4.4% among cases 14 to 19 years old (P.035) and 5.6% among cases age 20 to 39 (P.13). Cases with complete paraplegia had the highest 91-day incidence of VTE,

3 2242 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones Table 1: Clinical and Demographic Characteristics of Patients With SCI Variable Total VTE (1y) No VTE (1y) No. of cases 16, (6) 15,263 Mean age SD (y) Sex, n (%)* Male 11,777 (72.5) 768 (6.5) 11,009 Female 4463 (27.5) 209 (4.7) 4254 Race/ethnicity, n (%) White 9747 (60) 541 (5.6) 9206 African American 1919 (11.8) 177 (9.2) 1742 Hispanic 3188 (19.6) 198 (6.2) 2990 Asian/Pacific Islander 931 (5.7) 42 (4.5) 889 Other 455 (7.3) 19 (4.2) 436 Age, n (%) (y) (1.1) (4.8) (5.6) (6.7) (6.7) (6.4) (7.4) (6.1) (4.2) 1324 Extent of paralysis, n (%) Complete paraplegia 1017 (6.3) 121 (11.9) 896 Complete tetraplegia 1218 (7.5) 104 (8.5) 1114 Incomplete paraplegia (or not specified) 5608 (34.5) 368 (7.4) 5240 Incomplete tetraplegia (or not specified) 7395 (45.5) 354 (5.0) 7041 Unspecified level or extent 1002 (6.2) 30 (3) 972 Mean hospital LOS SD (d) Fracture of spine, n (%) 9489 (58.4) 683 (7.2) 8806 Tracheostomy performed, n (%) 1244 (7.7) 139 (11.7) 1105 Deaths, n (%) Died in acute care hospital 1052 (6.4) 60 (5.7) 992 Death 91d 1436 (8.8) 86 (6.0) 1350 Death 181d (not in hospital) 1623 (10) 101 (6.2) 1522 Death 365d (not in hospital) 1868 (11.5) 123 (6.6) 1745 Abbreviation: SD, standard deviation. *One patient did not have an assigned sex. 11%, compared with only 7.8% among cases with complete tetraplegia (P.009). There was but a slight difference in the incidence of VTE between university hospitals (6.7%) and the Percent of All Thromboembolism Cases (1y) 20% 16% 12% 8% 4% 0% > 80 Age (y) Men Fig 1. Age and sex distribution of the SCI cohort. Women large hospitals (7.4%) that had more than 350 beds (P.31), but both groups had a higher incidence than moderate-size hospitals with 250 to 350 beds (5.5%, P.001) and small hospitals (4.2%, P.001). Of the total 883 patients who developed a VTE within 91 days, 453 (51%) were diagnosed in the index hospital, and the remaining were diagnosed after a transfer or at the time of a rehospitalization in the index hospital. The results of multivariate logistic modeling of potential risk factors for developing VTE within 91 days of SCI are shown in table 2. Compared with the referent group of cases that were 30 to 49 years old, cases 8 to 13 years old had significantly lower odds of being diagnosed with VTE (odds ratio [OR] 0.2; 95% confidence interval [CI], ; P.01). Although not statistically significant, VTE risk was also lower among cases ages 14 to 19 (OR 0.7; 95% CI, ; P.03). There was no significant increase in the risk of VTE among cases over the age of 50. Other strong risk factors for VTE included being a male (OR 1.4; 95% CI, ), having complete paraplegia (relative to complete tetraplegia, OR 1.8; 95% CI, ), and being an African American (OR 1.6; 95% CI, ). Incomplete injuries (with the exception of incomplete paraplegia) and unspecified level injuries were associated with a lower risk of VTE compared with cases with complete tetraplegia. An

4 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones 2243 Incidence VTE Incidence Per 100 SCI Cases SCI Incidence Per 100,000 Adults Linear (SCI Incidence Per 100,000 Adults) Fig 2. Standardized yearly incidence of SCI and yearly incidence of VTE. increasing number of chronic comorbid conditions was associated with a modest increase in the odds of developing VTE, rising from an OR of 1.3 (95% CI, ) for 1 condition up to an OR of 1.6 (95% CI, ) when 3 or more conditions were present. When the specific comorbidities were analyzed, metastatic cancer had the strongest association (OR 2.5; 95% CI, ). Other significant comorbidities included: underlying chronic neurologic disease (OR 1.4; 95% CI, ), obesity (OR 1.9; 95% CI, ), history of psychiatric disease (OR 1.5; 95% CI, ), and depression/anxiety (OR 1.4; 95% CI, ). Only 322 (2%) of all the cases had an IVC filter; 119 (37%) of those cases were coded as having VTE, 33 (28%) with PE. In 60 of these cases it was determined that the filter was placed after the VTE event. Thirty-eight (15.7%) of the remaining 241 cases that presumably had a prophylactic filter were diagnosed with VTE after the filter was placed. An additional 21 cases had both a filter placed and VTE diagnosed during the same hospitalization, but the temporal sequence could not be determined. Thus, the incidence of VTE among cases with filters could have been as high as 59 (22.5%) of 262. In the first 91 days after injury 1436 (8.8%) subjects died. Mortality rose exponentially with age, from 3.3% of children under age 14, to 3.6% among cases age 30 to 39, to 7.4% among cases age 50 to 59, to 20.3% among cases 70 to 79 years old. As shown in table 2, significant predictors of death were male sex, advancing age, increasing comorbidity, hospitalization in a small hospital, and being tetraplegic. Indigent care cases were also associated with higher risk of dying within 91 days. Cases diagnosed with VTE within the first 91 days were not significantly more likely to die in the first 3 months after injury. DISCUSSION Comprehensive analysis of the incidence of VTE among SCI patients has been hampered because of the small numbers of patients reported in most series, 9,12,22 and by the highly select nature of the cases enrolled in registry studies. 1 To overcome these problems, we analyzed a large population-based SCI cohort. There were 2 unexpected findings: no change in the risk-adjusted incidence of VTE between 1991 and 2001, and no evidence that VTE was a significant predictor of death within 3 months of the injury. Strong predictors of VTE identified were male sex, African American race, an increasing number of comorbid medical conditions, tracheostomy placement, and paraplegia. Age less than 30 years was associated with a lower risk of developing VTE; age less than 14 had the lowest risk. Year Possible explanations for the lack of any reduction in VTE incidence over the 11-year period include: (1) no difference in the effectiveness of regular heparin and LMWH 4 coupled with no meaningful change in the frequency, intensity, or duration of medical thromboprophylaxis, (2) relative ineffectiveness of thromboprophylaxis in preventing symptomatic VTE in high risk patients, (3) an increase in the number of cases with asymptomatic VTE detected by screening ultrasound, offsetting a true decrease in the incidence of symptomatic VTE, (4) a secular trend of SCI patients being sicker and more prone to develop VTE, and (5) increased diagnostic suspicion of VTE by health workers and/or more complete diagnostic coding for VTE. Thus, the absence of any observed change might be explained by opposing secular trends, with an increase in the level of diagnostic suspicion leading to more diagnoses, combined with the use of more effective thromboprophylaxis, leading to a lower incidence, resulting in a net overall effect of no change in VTE incidence. However, it is also possible that thromboprophylaxis for SCI patients was fully optimized by the early 1990s and that use of LMWH in the past 10 years has not caused a reduction in the incidence of symptomatic VTE events. We did not find any evidence to suggest that VTE screening using ultrasound increased significantly during the study period. Because the administrative database we used contained no information about medication use or treatment, we were unable to assess the effect of the use or nonuse of thromboprophylaxis. However, it is highly unlikely that sicker patients, such as those with comorbid medical conditions, lower-extremity fracture, or who required tracheostomy, were not given any thromboprophylaxis. It is more likely that it was either started too late for some patients, or the dose was simply insufficient. Even after adjusting for multiple potential confounders, including hospital size, source of medical payment, etc, African Americans had a significantly higher risk of developing VTE, a finding that has not been previously reported. Although it is known that African Americans have a higher overall incidence of VTE events 23 and idiopathic VTE events, 16 no studies have specifically analyzed the effect of race and ethnicity on the incidence of VTE in SCI patients. Potential unmeasured confounders that might explain this finding include higher levels of factor VIII among blacks with SCI, 24 and potential underuse of Fig 3. Time of thromboembolic events diagnosed within 1 year of SCI.

5 2244 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones Table 2: Multivariate Analysis of Risk Factors for VTE or Death Within 91 Days Variable OR for VTE 91 Days 95% CI OR for Death 91 Days 95% CI Year (continuous by year) Sex Women (referent) Men Race/ethnicity White (referent) African American Asian/Pacific Islander Hispanic Other Age (y) * * * (referent) * Insurance status HMO (referent) Medi-Cal 1.3* Medicare Self-pay or other government Indigent * Elixhauser Comorbidity Index score 0 (referent) Hospital size (beds) University hospitals (referent) beds beds 0.7* beds 0.7* VTE NA NA Spinal fracture Trauma to lower extremity 1.3* Intervening hospitalization Tracheostomy Neurologic impairment Tetraplegia (referent) Paraplegia Unspecified tetraplegia Incomplete tetraplegia 0.8* Unspecified paraplegia 1.0* Incomplete paraplegia 1.2* Unspecified defect Abbreviations: HMO, health maintenance organization; NA, not applicable. *P.05. P.01. The number with VTE was too small to determine reliably the odds of VTE. Not entered into the model to predict death. medical prophylaxis. 25,26 It is also possible that race may be a marker for socioeconomic status, which in turn, has been associated with higher levels of morbidity than are captured in comorbidity measures 27 ; we did find an association between having Medicaid insurance and risk of VTE. Our findings confirm several prior reports that found a higher incidence of VTE in the weeks immediately after the SCI. 28,29 Although we could not determine the exact day when VTE was diagnosed, 774 (88%) of all the cases diagnosed with VTE during the first 3 months occurred in the index hospitalization or during a contiguous stay in a second hospital. Only 94 additional cases were diagnosed with VTE between 3 months and 12 months after injury. Finally, the time immediately after injury may be when thromboprophylaxis is least likely to be used. 30 Only a few studies have analyzed outcomes such as VTE among young children with SCI, probably because of the very

6 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones 2245 low incidence of SCI in the preadolescent population. 31 Although it is possible that a severe illness such as SCI might overwhelm the protective effects of younger age on thrombosis, our findings confirm that the risk of VTE was indeed significantly lower in young subjects age 13 through 19, and very low among children younger than 14 years old compared with the risk in middle-aged adults. In the 11-year period we studied, there were just 181 VTE cases age 13 or under, and only 8 of those were coded as having complete paraplegia or quadriplegia. This fact underscores the rarity of severe neurologic impairment in this population. In the risk-adjusted model, men were significantly more likely of developing VTE than women (OR 1.4). 1 The reason is unclear but it may be related to unmeasured differences in the overall type and severity of injuries sustained. Most studies of the epidemiology of VTE have reported little difference in the incidence between men and women after trauma or surgery. 23,32-34 The finding that complete paraplegia was associated with significantly greater risk of VTE than was complete tetraplegia has been reported by several investigators. 1,6 We have extended these findings by noting a higher risk of VTE among patients coded as having incomplete paraplegia compared with those with incomplete tetraplegia (OR 1.4; 95% CI, ). Further research is needed to determine if degree of spasticity, intensity of thromboprophylaxis, or other unidentified comorbidities explain this difference. The strongest predictors of death were age over 80 years, placement of a tracheostomy, presence of 3 or more chronic comorbid medical conditions, and tetraplegia. Diagnosis of VTE was not a significant predictor, perhaps because of the relatively low number of cases with PE among the VTE cases. Overall, only 24% of all the SCI cases with VTE had PE, which is much lower than the prevalence of PE (33%) typically reported among cohorts with VTE. 35 The finding that cases that were treated with a prophylactic IVC filter had a very high incidence of VTE, approximately 15% to 23% is difficult to interpret. Most of these patients were very sick with multiple injuries, which may have precluded use of thromboprophylaxis. Because of this bias, no firm conclusions should be drawn about the effectiveness of IVC filters. The finding that cases from small hospitals had a higher incidence of VTE in the risk-adjusted model may reflect a difference in diagnostic bias or severity of initial injury. Transfers of sicker patients to larger hospitals does not account for this finding since we used only the index hospital in the analysis. CONCLUSIONS The incidence of VTE within 91 days of acute SCI averaged 5.4%, with a range of 3% to 12%, depending on whether specific risk factors were present. Unexpectedly, the incidence did not change significantly during the 11-year period. If further studies verify that VTE is indeed associated with the specific risk factors we identified, the incidence of VTE might be further reduced by identifying the highest risk patients as soon as possible after hospital admission and initiating a thromboprophylaxis regimen. 30 Conversely, the very low risk of VTE associated with children younger than 14 years old may lead to standards of care that limit exposure of this age group to the risks of prophylaxis. APPENDIX 1: CODING CATEGORIZATION BY SPINAL CORD LEVEL AND COMPLETENESS OF INJURY Complete Paraplegia Incomplete Paraplegia Unspecified Paraplegia Complete Tetraplegia Incomplete Tetraplegia Unspecified Tetraplegia Unspecified Complete lesion of thoracic or lumbar cord Anterior cord Central cord Posterior cord Sacrum and coccyx, complete cauda equina Cauda equina Sacrum and coccyx, other cauda equina Unspecified SCI of thoracic or lumbar cord Lumbar Sacral Sacrum and coccyx, unspecified or other SCI Complete lesion of cervical cord Anterior cord Central cord Posterior cord Unspecified SCI of cervical cord

7 2246 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones Explanations for categorization 806: SCI with fracture : sacrum and coccyx, closed with unspecified SCI categorized as unspecified. Although most likely this represents incomplete injury, the coding makes it unspecified : sacrum and coccyx, closed with complete cauda equina lesion categorized as incomplete injury. Cauda equina injuries typically have motor incomplete pattern of injury : sacrum and coccyx, closed with other cauda equina injury categorized as incomplete. As stated above, unless otherwise specified, cauda equina will have an incomplete motor pattern of injury : sacrum and coccyx, closed with other SCI categorized as unspecified. Most likely incomplete pattern, but the coding is nonspecific : sacrum and coccyx, open with unspecified SCI categorized as unspecified. See above code : sacrum and coccyx, open with complete cauda equina lesion categorized as complete. See above code : sacrum and coccyx, open with other cauda equina injury categorized as unspecified. See above code : sacrum and coccyx, open with other SCI categorized as unspecified. See above code : lumbar, closed categorized as unspecified : lumbar, open categorized as incomplete. 952: SCI without fracture : lumbar categorized as unspecified : sacral categorized as incomplete... para/unable to state complete or incomplete : cauda equine categorized as incomplete , 806.9, 952.8, and are unspecified levels of SCI categorized as unspecified. References 1. Chen D, Apple D, Hudson L, Bode R. Medical complications during acute rehabilitation following spinal cord injury current experience of the Model Systems. Arch Phys Med Rehabil 1999; 80: Deep K, Jigajinni MV, McLean AN, Fraser MH. Prophylaxis of thromboembolism in spinal injuries results of enoxaparin used in 276 patients. Spinal Cord 2001;39: Weingarden SI. Deep venous thrombosis in spinal cord injury; overview of the problem. Chest 1992;102:636S-9S. 4. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 2003;54: ; discussion Green D. Diagnosis, prevalence, and management of thromboembolism in patients with spinal cord injury. J Spinal Cord Med 2003;26: Waring W, Karunas R. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease. Paraplegia 1991;29: Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331: Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):338S- 400S. 9. Green D, Hartwig D, Chen D, Soltysik R, Yarnold P. Spinal Cord Injury Risk Assessment for Thromboembolism (SPIRATE Study). Am J Phys Med Rehabil 2003;82: Green DC. Prevention of thromboembolism in spinal cord injury. Consortium for spinal cord medicine clinical practice guidelines. Washington (DC): Paralyzed Veterans of America; DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil 1999;80: Winemiller M, Stolp-Smith K, Silverstein M, Therneau T. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. J Spinal Cord Med 1999;22: Levy M, Granvill R, Hart D, Meltzer H. Deep venous thrombosis in children and adolescents. J Neurosurg Pediatr 2004; 101: White RH, Zhou H, Romano PS. Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med 1998;158: Meux E. Encrypting personal identifiers. Health Serv Res 1994; 29: White R, Zhou H, Romano P. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128: White RH, Brickner LA, Scannell KA. ICD-9-CM codes poorly identified venous thromboembolism during pregnancy. J Clin Epidemiol 2004;57: Zakai N, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemostasis 2004;2: Kniffin W Jr, Baron J, Barrett J, Birkmeyer J, Anderson F Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154: Cushman M, Tsai A, White R, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004;117: Elixhauser A, Steiner C, Harris D, Coffey R. Comorbidity measures for use with administrative data. Med Care 1998;36: Merli GJ, Crabbe S, Doyle L, Ditunno JF, Herbison GJ. Mechanical plus pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury. Paraplegia 1992;30: Stein PD, Hull RD, Patel KC, et al. Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med 2003;163: Patel RK, Ford E, Thumpston J, Arya R. Risk factors for venous thrombosis in the black population. Thromb Haemost 2003;90: Green D, Twardowski P, Wei R, Rademaker AW. Fatal pulmonary embolism in spinal cord injury. Chest 1994;105: Guihan M, Simmons B, Nelson A, Bosshart HT, Burns SP. Spinal cord injury providers perceptions of barriers to implementing selected clinical practice guideline recommendations. J Spinal Cord Med 2003;26: Seeman TE, Crimmins E, Huang MH, et al. Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging. Soc Sci Med 2004;58: Gondim FA, Lopes AC Jr, Oliveira GR, et al. Cardiovascular control after spinal cord injury. Curr Vasc Pharmacol 2004;2: Bravo G, Guizar-Sahagun G, Ibarra A, Centurion D, Villalon CM. Cardiovascular alterations after spinal cord injury: an overview. Curr Med Chem Cardiovasc Hematol Agents 2004; 2:

8 VENOUS THROMBOEMBOLISM AFTER SPINAL CORD INJURY, Jones Aito S, Pieri A, D Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord 2002;40: Radecki R, Gaebler-Spira D. Deep vein thrombosis in the disabled pediatric population. Arch Phys Med Rehabil 1994;75: Silverstein MD, Heit JA, Mohr DN, Petterson TM, O Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158: Heit J, Silverstein M, Mohr D, Petterson T, O Fallon W, Melton LR. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160: White RH, Murin S, Zhou H, Harvey DJ. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population California in Thrombosis Haemost 2005; 93: Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002;88: Supplier a. Version 82; StataCorp, 4905 Lakeway Dr, College Station, TX

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 4.3 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Venous Thromboembolism (VTE) Set Measure Set I #: Performance Measure Name: Intensive

More information

The Epidemiology of Venous Thromboembolism

The Epidemiology of Venous Thromboembolism The Epidemiology of Venous Thromboembolism Richard H. White, MD Abstract Venous thromboembolism (VTE) occurs for the first time in 100 persons per 100,000 each year in the United States, and rises exponentially

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form. Performance Measure Name: Venous Thromboembolism Prophylaxis

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form. Performance Measure Name: Venous Thromboembolism Prophylaxis Last Updated: Version 4.3 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Venous Thromboembolism (VTE) Set Measure Set I #: Performance Measure Name: Venous

More information

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge ORIGINAL CLINICAL INVESTIGATION Open Access Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge Li Wang 1, Nishan

More information

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein

More information

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability

More information

Medical Patients: A Population at Risk

Medical Patients: A Population at Risk Case Vignette A 68-year-old woman with obesity was admitted to the Medical Service with COPD and pneumonia and was treated with oral corticosteroids, bronchodilators, and antibiotics. She responded well

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery

Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery Chatupon Chotigavanichaya MD*, Monchai Ruangchainikom MD*, Choompon Piyavanno MD*, Ekkapoj Korwutthikulrangsri MD*, Sirichai Wilartratsami

More information

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS The West London Medical Journal 2010 Vol 2 No 4 pp 19-24 AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS Soneji ND Agni NR Acharya MN Anjari

More information

EAST MULTICENTER STUDY DATA DICTIONARY

EAST MULTICENTER STUDY DATA DICTIONARY EAST MULTICENTER STUDY DATA DICTIONARY Does the Addition of Daily Aspirin to Standard Deep Venous Thrombosis Prophylaxis Reduce the Rate of Venous Thromboembolic Events? Data Entry Points and appropriate

More information

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS Samuel Z. Goldhaber, MD Director, VTE Research Group Cardiovascular Division Brigham and Women s Hospital Professor of Medicine Harvard Medical

More information

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008 Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone

More information

VTE in the Trauma Population

VTE in the Trauma Population VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of

More information

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE

More information

Functional Outcomes among the Medically Complex Population

Functional Outcomes among the Medically Complex Population Functional Outcomes among the Medically Complex Population Paulette Niewczyk, PhD, MPH Director of Research Uniform Data System for Medical Rehabilitation 2015 Uniform Data System for Medical Rehabilitation,

More information

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis Reducing Harm Improving Healthcare Protecting Canadians VENOUS THROMBOEMBOLISM PREVENTION Getting Started Kit Section 2: Evidence-Based Appropriate VTE Prophylaxis January 2017 www.patientsafetyinstitute.ca

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

ORIGINAL RESEARCH. BACKGROUND: The clinical venous thromboembolism (VTE) burden remains high in the United States, despite guidelines

ORIGINAL RESEARCH. BACKGROUND: The clinical venous thromboembolism (VTE) burden remains high in the United States, despite guidelines ORIGINAL RESEARCH Inpatient Thromboprophylaxis Use in U.S. Hospitals: Adherence to the Seventh American College of Chest Physician s Recommendations for At-risk Medical and Surgical Patients Alpesh N.

More information

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012 THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012 Background Trauma Patients at High Risk for VTE Spain, D.A.,

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593 Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

In each hospital-year, we calculated a 30-day unplanned. readmission rate among patients who survived at least 30 days

In each hospital-year, we calculated a 30-day unplanned. readmission rate among patients who survived at least 30 days Romley JA, Goldman DP, Sood N. US hospitals experienced substantial productivity growth during 2002 11. Health Aff (Millwood). 2015;34(3). Published online February 11, 2015. Appendix Adjusting hospital

More information

TECHNICAL NOTES. for Spinal Fusion. June 2016

TECHNICAL NOTES. for Spinal Fusion. June 2016 TECHNICAL NOTES for Spinal Fusion June 2016 Pennsylvania Health Care Cost Containment Council Report Period: Calendar Year 2014 January 1, 2014 through December 31, 2014 Discharges 225 Market Street, Suite

More information

Prevention of Venous Thromboembolism in High-Risk Patients

Prevention of Venous Thromboembolism in High-Risk Patients Prevention of Venous Thromboembolism in High-Risk Patients William H. Geerts The prevention of venous thromboembolism (VTE) in patients recovering from major trauma, spinal cord injury (SCI), or other

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

Acute Spinal Cord Injuries and the Incidence of Clinically Occurring Thromboembolic Disease

Acute Spinal Cord Injuries and the Incidence of Clinically Occurring Thromboembolic Disease ParapkgitJ 29 (1991) 8-16 1991 International Medical Society of Paraplegia Paraplegia Acute Spinal Cord Injuries and the Incidence of Clinically Occurring Thromboembolic Disease W. P. Waring, MS, MD,I,2

More information

Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma

Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma Ian E. Brown, MD, PhD, and Joseph M. Galante MD, FACS Formatted: Font: 16 pt, Bold Formatted: Centered Formatted: Font: Bold

More information

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Slide 1. Slide 2. Slide 3. Outline of This Presentation Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous

More information

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism? Is thromboprophylaxis effective in reducing the pulmonary thromboembolism? Fereshteh Rajabi (1), Masoumeh Sadeghi (2), Fereshteh Karbasian (3), Ali Torkan (4) Abstract BACKGROUND: Deep vein thrombosis

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Appendix Identification of Study Cohorts

Appendix Identification of Study Cohorts Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures

More information

Incidence of deep vein thrombosis after major spine surgeries with no mechanical or chemical prophylaxis

Incidence of deep vein thrombosis after major spine surgeries with no mechanical or chemical prophylaxis 29 29 33 Incidence of deep vein thrombosis after major spine surgeries with no mechanical or chemical prophylaxis Author Institution Sreedharan Namboothiri Kovai Medical Center and Hospitals, Coimbatore,

More information

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE Results from

More information

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Society of Trauma Nurses TraumaCon 03/22/2018

Society of Trauma Nurses TraumaCon 03/22/2018 Prophylaxis Against Venous Thromboemblism (VTE) in Pediatric Trauma Society of Trauma Nurses TraumaCon 03/22/2018 Arash Mahajerin, MD, MSCr Hematology, CHOC Children s Specialists Orange, CA Disclosure

More information

Incidence of Diagnosed Deep Vein Thrombosis in the General Population: Systematic Review

Incidence of Diagnosed Deep Vein Thrombosis in the General Population: Systematic Review Eur J Vasc Endovasc Surg 25, 1±5 (2003) doi:10.1053/ejvs.2002.1778, available online at http://www.sciencedirect.com on REVIEW Incidence of Diagnosed Deep Vein Thrombosis in the General Population: Systematic

More information

Prevention of Venous Thromboembolism in Department of Veterans Affairs Hospitals

Prevention of Venous Thromboembolism in Department of Veterans Affairs Hospitals ORIGINAL RESEARCH Prevention of Venous Thromboembolism in Department of Veterans Affairs Hospitals Jerome Herbers, MD, MBA Susan Zarter, BSN Department of Veterans Affairs, Office of the Inspector General,

More information

Prevention of Venous Thromboembolism

Prevention of Venous Thromboembolism Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

ORIGINAL INVESTIGATION. Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty

ORIGINAL INVESTIGATION. Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty ORIGINAL INVESTIGATION Incidence and Time Course of Thromboembolic Outcomes Following or Knee Arthroplasty Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; Juan Rodrigo, MD; William Bargar,

More information

TOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES

TOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES TOTAL HIP AND KNEE REPLACEMENTS FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES The Pennsylvania Health Care Cost Containment Council April 2005 Preface This document serves as

More information

DATA FROM THE POPULAtion-based

DATA FROM THE POPULAtion-based ORIGINAL INVESTIGATION Venous Thromboembolism in the Outpatient Setting Frederick A. Spencer, MD; Darleen Lessard, MS; Cathy Emery, RN; George Reed, PhD; Robert J. Goldberg, PhD Background: There has been

More information

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria

More information

Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer

Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer Blood Coagulation, Fibrinolysis and Cellular Haemostasis 255 Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer Carlos Martinez

More information

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

BACKGROUND AND OBJECTIVE: Hospital-acquired venous thromboembolic events

BACKGROUND AND OBJECTIVE: Hospital-acquired venous thromboembolic events QUALITY IMPROVEMENT/RISK MANAGEMENT Innovative Approaches to Increase Deep Vein Thrombosis Prophylaxis Rate Resulting in a Decrease in Hospital-Acquired Deep Vein Thrombosis at a Tertiary-Care Teaching

More information

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital

More information

PROGNOSIS AND SURVIVAL

PROGNOSIS AND SURVIVAL CANCER ASSOCIATED THROMBOSIS PROGNOSIS AND SURVIVAL Since French internist Armand Trousseau reported the occurrence of mysterious thrombotic disorders in cancer patients in the mid-19th century, the link

More information

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

Utilization of DVT Prophylaxis in non ICU Hospitalized Patients

Utilization of DVT Prophylaxis in non ICU Hospitalized Patients Asian Pacific Journal of Tropical Disease (2012)S707-S711 707 Contents lists available at ScienceDirect Asian Pacific Journal of Tropical Disease journal homepage:www.elsevier.com/locate/apjtd Document

More information

CANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital

CANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital CANCER ASSOCIATED THROMBOSIS Pankaj Handa Department of General Medicine Tan Tock Seng Hospital My Talk Today 1.Introduction 2. Are All Cancer Patients at Risk of VTE? 3. Should All VTE Patients Be Screened

More information

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures 1 Predicting Venous Thromboembolic Complications following Neurosurgical Procedures David Dornbos III, Varun Shah, Blake Priddy, Victoria Schunemann, Ciarán Powers Venous Thromboembolic (VTE) Complications

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set

More information

Thromboembolic events (TEs), such as deep vein

Thromboembolic events (TEs), such as deep vein An Original Study Use of Low-Molecular-Weight Heparin and a Deep Vein Thrombosis Protocol to Prevent DVT in Elderly Patients With Trauma Douglas J.E. Schuerer, MD, and Joseph Borrelli, Jr., MD Abstract

More information

Handbook for Venous Thromboembolism

Handbook for Venous Thromboembolism Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and

More information

Venous Thromboembolism. Prevention

Venous Thromboembolism. Prevention Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and

More information

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations General Guideline Title Prevention of deep vein thrombosis and pulmonary embolism. Bibliographic Source(s) American College of Obstetricians and Gynecologists (ACOG). Prevention of deep vein thrombosis

More information

Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore

Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore Epidemiology of Venous Thromboembolism in the East Heng Joo NG Department of Haematology Singapore General Hospital Singapore Early Literature Tinckler LF Br Med J 1964;1:502 Propagating a notion.. Hwang

More information

Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A

Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

How long to continue anticoagulation after DVT?

How long to continue anticoagulation after DVT? How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September

More information

Ankle fractures are one of

Ankle fractures are one of Elevated Risks of Ankle Fracture Surgery in Patients With Diabetes Nelson F. SooHoo, MD, Lucie Krenek, MD, Michael Eagan, MD, and David S. Zingmond, MD, PhD Ankle fractures are one of the most common types

More information

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study IMPROVING PATIENT SAFETY Preventing & Managing Venous Thromboembolism Session 8 Data Driving Strategies for VTE Prevention and Management 3/30/2012; 15.35-15.55 Symptomatic Venous Thromboembolism after

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Prada D, Zhong J, Colicino E, et al. Association

More information

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.

More information

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction Venous Thromboembolism Prophylaxis following Lower Extremity Orthopedic Surgery: A Review of the Biomedical Research Literature and Evidence-Based Policy in the United States. Adam Goldfarb, M.A., D.C.,

More information

Proper Diagnosis of Venous Thromboembolism (VTE)

Proper Diagnosis of Venous Thromboembolism (VTE) Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials

Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials Winner of the AAHKS Award Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials Greg A. Brown, MD, PhD The Journal of Arthroplasty Vol. 24

More information

Venous Thromboembolism National Hospital Inpatient Quality Measures

Venous Thromboembolism National Hospital Inpatient Quality Measures Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation

More information

Venous Thromboembolism Prophylaxis: Checked!

Venous Thromboembolism Prophylaxis: Checked! Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer

More information

Research Article Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients

Research Article Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients rombosis Volume 2015, Article ID 849142, 6 pages http://dx.doi.org/10.1155/2015/849142 Research Article Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically

More information

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH Venous Thrombo-Embolism John de Vos Consultant Haematologist RSCH overview The statistics Pathogenesis Prophylaxis Treatment Agent Duration Incidental VTE Recurrence of VTE IVC filters CVC related thrombosis

More information

Deep venous thrombosis (DVT) is a common problem among

Deep venous thrombosis (DVT) is a common problem among Update When Can the Patient With Deep Venous Thrombosis Begin to Ambulate? Deep venous thrombosis (DVT) is a common problem among hospitalized patients, 1 even those who receive prophylaxis. 2 Patients

More information

Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation Wilson R D, Murray P K

Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation Wilson R D, Murray P K Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation Wilson R D, Murray P K Record Status This is a critical abstract of an economic evaluation that

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

New Zealand Spinal Cord Injury Registry. First Annual Report August 2016 to July 2017

New Zealand Spinal Cord Injury Registry. First Annual Report August 2016 to July 2017 New Zealand Spinal Cord Injury Registry First Annual Report August 216 to July 217 2 The New Zealand Spinal Cord Injury Registry (NZSCIR) would like to acknowledge the spinal service clinicians and coordinators

More information

Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis

Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis Eur Spine J (2008) 17:970 974 DOI 10.1007/s00586-008-0668-z ORIGINAL ARTICLE Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis C.

More information

Venous Thrombosis in Asia

Venous Thrombosis in Asia Venous Thrombosis in Asia Pantep Angchaisuksiri, M.D. Professor of Medicine, Mahidol University, Thailand Adjunct Associate Professor, University of North Carolina, Chapel Hill, USA Venous Thromboembolism

More information

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is

More information

Morbidity Aspects in Spinal Cord Injury Patients: Experience of the Spinal Unit at King Hussein Medical Center

Morbidity Aspects in Spinal Cord Injury Patients: Experience of the Spinal Unit at King Hussein Medical Center Morbidity Aspects in Spinal Cord Injury Patients: Experience of the Spinal Unit at King Hussein Medical Center Ali H. Otom MD, D. Med Rehab (RCP)* ABSTRACT Objectives: To investigate the frequency of medical

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

Recent Trends in Clinical Outcomes and Resource Utilization for Pulmonary Embolism in the United States. Findings From the Nationwide Inpatient Sample

Recent Trends in Clinical Outcomes and Resource Utilization for Pulmonary Embolism in the United States. Findings From the Nationwide Inpatient Sample CHEST Recent Trends in Clinical Outcomes and Resource Utilization for Pulmonary Embolism in the United States Findings From the Nationwide Inpatient Sample Brian Park, MD; Louis Messina, MD; Phong Dargon,

More information

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms DATE: 23 August 2011 CONTEXT AND POLICY ISSUES: Thromboembolism occurs when a blood

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Comparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project

Comparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project Comparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project Dr. Jonathan Laxton, FRCPC, R5 GIM University of Manitoba

More information

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients? July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous

More information

TRANSPARENCY COMMITTEE OPINION. 18 April 2007

TRANSPARENCY COMMITTEE OPINION. 18 April 2007 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 April 2007 ARIXTRA 2.5 mg/0.5 ml, solution for injection in prefilled syringe Pack of 2 (CIP: 359 225-4) Pack of

More information

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Venous Thromboembolism (VTE): Prophylaxis and the Incidence of Hospital Acquired VTE(HAQ VTE) Olaide Akande, MBChB Mentor: John Hall, MD, FACP

Venous Thromboembolism (VTE): Prophylaxis and the Incidence of Hospital Acquired VTE(HAQ VTE) Olaide Akande, MBChB Mentor: John Hall, MD, FACP Venous Thromboembolism (VTE): Prophylaxis and the Incidence of Hospital Acquired VTE(HAQ VTE) Olaide Akande, MBChB Mentor: John Hall, MD, FACP Outline Rationale Background Objective Methods Results Conclusion

More information

PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES

PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES Mario Mandalà, MD Unit of Clinical Research Department of Oncology and Haematology Papa Giovanni XXIII Hospital Cancer Center

More information

Epidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione

Epidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Epidemiologia e clinica del tromboembolismo venoso Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Thrombophilia may present clinically as one or more of several thrombotic manifestations

More information

Audit of perioperative management of patients with fracture neck of femur

Audit of perioperative management of patients with fracture neck of femur Audit of perioperative management of patients with fracture neck of femur *M Dissanayake 1, N Wijesuriya 2 Registrar in Anaesthesia 1, Consultant Anaesthetist 2, North Colombo Teaching Hospital, Ragama,

More information